Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Max Robinson

Showing results (81-90 of 111) with videos related to

Pageof 12
Sort By:
Health Technology Assessment (Winchester, England)|April 15, 2017
PET-NECK: a multicentre randomised Phase III non-inferiority trial comparing a positron emission tomography-computerised tomography-guided watch-and-wait policy with planned neck dissection in the management of locally advanced (N2/N3) nodal metastases in patients with squamous cell head and neck cancerHisham Mehanna, Chris C McConkey, Joy K Rahman, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 1, 2019
Comparison of Molecular Assays for HPV Testing in Oropharyngeal Squamous Cell Carcinomas: A Population-Based Study in Northern IrelandStephanie G Craig, Lesley A Anderson, Michael Moran, et al.
Cancers|November 14, 2019
Collagen Induces a More Proliferative, Migratory and Chemoresistant Phenotype in Head and Neck Cancer via DDR1Sook Ling Lai, May Leng Tan, Robert J Hollows, et al.
The Journal of Pathology|May 8, 2026
An oncogenic role for EBV-encoded BILF1 in nasopharyngeal carcinomaAnna Kc Wong, Vinotheni Rajendran, Lucia Mundo, et al.
Human Genome Variation|April 16, 2016
Genomic architecture of inflammatory bowel disease in five families with multiple affected individualsAnna B Stittrich, Justin Ashworth, Mude Shi, et al.
Molecular Neurodegeneration|May 7, 2021
Modulating innate immune activation states impacts the efficacy of specific Aβ immunotherapyYona Levites, Cory Funk, Xue Wang, et al.
British Journal of Cancer|March 21, 2019
Recommendations for determining HPV status in patients with oropharyngeal cancers under TNM8 guidelines: a two-tier approachStephanie G Craig, Lesley A Anderson, Andrew G Schache, et al.
The New England Journal of Medicine|March 24, 2016
PET-CT Surveillance versus Neck Dissection in Advanced Head and Neck CancerHisham Mehanna, Wai-Lup Wong, Christopher C McConkey, et al.
Scientific Reports|December 10, 2016
HOPX functions as a tumour suppressor in head and neck cancerLee Fah Yap, Sook Ling Lai, Sathya Narayanan Patmanathan, et al.
Head & Neck|April 5, 2016
Transoral laser microsurgery for oropharyngeal squamous cell carcinoma: A paradigm shift in therapeutic approachMark D Wilkie, Navdeep S Upile, Andrew S Lau, et al.
Pageof 12

Showing results (81-90 of 111) with videos related to

Sort By:
Pageof 12
Health Technology Assessment (Winchester, England)|April 15, 2017
PET-NECK: a multicentre randomised Phase III non-inferiority trial comparing a positron emission tomography-computerised tomography-guided watch-and-wait policy with planned neck dissection in the management of locally advanced (N2/N3) nodal metastases in patients with squamous cell head and neck cancerHisham Mehanna, Chris C McConkey, Joy K Rahman, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 1, 2019
Comparison of Molecular Assays for HPV Testing in Oropharyngeal Squamous Cell Carcinomas: A Population-Based Study in Northern IrelandStephanie G Craig, Lesley A Anderson, Michael Moran, et al.
Cancers|November 14, 2019
Collagen Induces a More Proliferative, Migratory and Chemoresistant Phenotype in Head and Neck Cancer via DDR1Sook Ling Lai, May Leng Tan, Robert J Hollows, et al.
The Journal of Pathology|May 8, 2026
An oncogenic role for EBV-encoded BILF1 in nasopharyngeal carcinomaAnna Kc Wong, Vinotheni Rajendran, Lucia Mundo, et al.
Human Genome Variation|April 16, 2016
Genomic architecture of inflammatory bowel disease in five families with multiple affected individualsAnna B Stittrich, Justin Ashworth, Mude Shi, et al.
Molecular Neurodegeneration|May 7, 2021
Modulating innate immune activation states impacts the efficacy of specific Aβ immunotherapyYona Levites, Cory Funk, Xue Wang, et al.
British Journal of Cancer|March 21, 2019
Recommendations for determining HPV status in patients with oropharyngeal cancers under TNM8 guidelines: a two-tier approachStephanie G Craig, Lesley A Anderson, Andrew G Schache, et al.
The New England Journal of Medicine|March 24, 2016
PET-CT Surveillance versus Neck Dissection in Advanced Head and Neck CancerHisham Mehanna, Wai-Lup Wong, Christopher C McConkey, et al.
Scientific Reports|December 10, 2016
HOPX functions as a tumour suppressor in head and neck cancerLee Fah Yap, Sook Ling Lai, Sathya Narayanan Patmanathan, et al.
Head & Neck|April 5, 2016
Transoral laser microsurgery for oropharyngeal squamous cell carcinoma: A paradigm shift in therapeutic approachMark D Wilkie, Navdeep S Upile, Andrew S Lau, et al.
Pageof 12